MRM Medirom Healthcare Technologies Inc. Annual reports only
Services-Personal Services · Nasdaq · SEC CIK 1819704 · Reporting currency JPY · Fiscal year ends 12/31
Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY21.5%
TTM net income YoY28.9%
TTM EPS YoY27.7%
Revenue 3-yr CAGR15.3%
Net income 3-yr CAGR—
Margins
Gross margin27.1%
Operating margin-0.2%
Net margin1.8%
FCF margin-16.9%
EBITDA margin3.3%
Returns
ROE26.0%
ROA2.0%
ROIC (approx.)-1.1%
Asset turnover1.11x
Leverage & solvency
Liabilities / assets85.3%
Debt / equity1.48x
Current ratio0.65x
Interest coverage-0.36x
Cash quality & payout
Operating cash flow / net income-8.95x
Accruals ratio19.8%
Payout ratio—
Capex / revenue0.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: JPY | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 6.23B | 8.30B | 6.83B | 6.95B | 5.41B |
| Cost of revenue | — | 6.05B | 5.26B | 5.05B | — |
| Gross profit | — | 2.25B | 1.57B | 1.90B | — |
| SG&A expense | 2.57B | 2.24B | 1.96B | 1.81B | 1.82B |
| Operating income | -3.39B | -18.10M | -391.58M | 96.97M | -470.59M |
| Interest expense | 66.19M | 49.74M | 36.87M | 9.80M | 11.95M |
| Pretax income | -3.34B | 47.71M | 20.62M | 179.77M | -414.48M |
| Income tax | 304.12M | -90.48M | -94.43M | 30.81M | 576.25M |
| Net income | -3.63B | 148.76M | 115.40M | 148.97M | -990.73M |
| EBITDA | -2.86B | 271.94M | -138.98M | 281.02M | -344.34M |
| EPS (basic) | -459.92 | 29.13 | 23.64 | 30.54 | -203.13 |
| EPS (diluted) | -459.92 | 28.52 | 22.34 | 27.23 | -203.13 |
| Weighted avg. shares (diluted) | 7.90M | 5.85M | 5.17M | 5.47M | 4.88M |
| Balance sheet | |||||
| Cash & equivalents | 91.98M | 329.40M | 106.35M | 605.45M | 370.62M |
| Short-term investments | 6.16M | 6.16M | 26.50M | 26.50M | 26.53M |
| Receivables | 671.66M | 1.36B | 621.87M | 534.69M | 312.30M |
| Inventory | 156.62M | 151.64M | 139.98M | 114.11M | 18.70M |
| Current assets | 1.49B | 2.71B | 1.76B | 2.36B | 1.38B |
| PP&E, net | 154.62M | 435.66M | 451.50M | 424.29M | 425.00M |
| Goodwill | 0 | 389.13M | 484.56M | 539.49M | 600.33M |
| Intangibles | 862.65M | 1.14B | 920.70M | 403.67M | 391.04M |
| Total assets | 4.68B | 8.09B | 6.85B | 6.75B | 5.75B |
| Current liabilities | 4.73B | 4.18B | 3.56B | 3.64B | 3.20B |
| Short-term debt | 161.32M | 620.81M | 100.42M | 99.17M | 162.25M |
| Long-term debt | 799.96M | 764.20M | 1.05B | 1.15B | 746.59M |
| Total debt | 961.28M | 1.39B | 1.15B | 1.25B | 908.84M |
| Total liabilities | 7.11B | 6.90B | 6.63B | 6.81B | 5.96B |
| Shareholders' equity | -2.67B | 933.27M | 210.88M | -59.38M | -208.34M |
| Net debt | 869.30M | 1.06B | 1.04B | 643.48M | 538.22M |
| Shares outstanding | 7.90M | 2,024 | — | — | — |
| Cash flow statement | |||||
| Operating cash flow | -1.16B | -1.33B | -631.74M | -685.70M | -557.23M |
| Capital expenditure | 10.30M | 71.41M | 135.84M | 120.74M | 95.65M |
| Free cash flow | -1.17B | -1.40B | -767.58M | -806.44M | -652.88M |
| Investing cash flow | -22.46M | 361.39M | -328.58M | 580.44M | -83.94M |
| Financing cash flow | 940.04M | 1.19B | 461.21M | 340.10M | -427.95M |
| Depreciation & amortization | 532.66M | 290.04M | 252.59M | 184.06M | 126.24M |
| Stock-based compensation | 0 | — | — | — | 196.85M |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Amounts are in the company's reporting currency, JPY, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.